Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neang S Ly

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Antimicrobial Agents and Chemotherapy|March 10, 2010
Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic modelJürgen B Bulitta, Jenny C Yang, Liliana Yohonn, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2016
Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosaNeang S Ly, Zackery P Bulman, Jürgen B Bulitta, et al.
The Journal of Antimicrobial Chemotherapy|February 26, 2015
Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistanceNeang S Ly, Jürgen B Bulitta, Gauri G Rao, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modelingJürgen B Bulitta, Neang S Ly, Cornelia B Landersdorfer, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2013
New dosing strategies for an old antibiotic: pharmacodynamics of front-loaded regimens of colistin at simulated pharmacokinetics in patients with kidney or liver diseaseGauri G Rao, Neang S Ly, Curtis E Haas, et al.
The Journal of Antimicrobial Chemotherapy|August 6, 2016
Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategiesGauri G Rao, Neang S Ly, Jürgen B Bulitta, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Antimicrobial Agents and Chemotherapy|March 10, 2010
Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic modelJürgen B Bulitta, Jenny C Yang, Liliana Yohonn, et al.
Antimicrobial Agents and Chemotherapy|March 2, 2016
Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosaNeang S Ly, Zackery P Bulman, Jürgen B Bulitta, et al.
The Journal of Antimicrobial Chemotherapy|February 26, 2015
Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistanceNeang S Ly, Jürgen B Bulitta, Gauri G Rao, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modelingJürgen B Bulitta, Neang S Ly, Cornelia B Landersdorfer, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2013
New dosing strategies for an old antibiotic: pharmacodynamics of front-loaded regimens of colistin at simulated pharmacokinetics in patients with kidney or liver diseaseGauri G Rao, Neang S Ly, Curtis E Haas, et al.
The Journal of Antimicrobial Chemotherapy|August 6, 2016
Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategiesGauri G Rao, Neang S Ly, Jürgen B Bulitta, et al.
Pageof 2